Cancer in dogs
One of the higher-stakes claim categories — and pre-existing handling decides whether you're covered.
What is canine cancer?
Cancer in dogs covers a broad range of malignancies — lymphoma, osteosarcoma, hemangiosarcoma, mast cell tumours, mammary tumours, and many others. Incidence increases sharply with age, and certain breeds (Golden Retrievers, Boxers, Rottweilers, Bernese Mountain Dogs) have well- documented higher rates. Early detection materially improves outcomes; many practices now include cancer screening in senior-pet wellness checks.
Treatment scope
- Diagnostic workup (biopsy, imaging, blood work)
- Surgical removal
- Chemotherapy (often multiple cycles)
- Radiation therapy (referral to specialist centre)
- Immunotherapy + targeted therapies (newer, sometimes off-label)
- Palliative care
What pet insurance considerations matter most
- Pre-existing handling. If a mass was noted at any prior vet visit — even as "monitor" — it can be flagged pre-existing for related cancer claims later. The earliest wellness check sets the baseline.
- Cancer-specific sub-limits. Some policies cap cancer claims separately from the annual benefit limit; some don't. Read the wording.
- Alternative therapy cover. Some policies exclude experimental or "newer" treatments. The line between standard-of-care and experimental moves fast in oncology.
- Renewal-age cap. Cancer claim rates rise in senior years; cover that stops renewing past 9-12 leaves the highest-risk decade uninsured.
- Breed-specific exclusions. Some insurers maintain breed-condition exclusions for cancers strongly associated with specific breeds.
Use /find-my-policy with the relevant scenarios to compare NZ policies on cancer cover language.
Not personalised veterinary or financial advice. Speak to a veterinary oncologist about treatment options; quote with each insurer for actual prices.